-
Innovation Ranking
Innovation Ranking – Hwa Create Corporation Ltd
Hwa Create Corporation Ltd (Hwa Create) is a provider of simulation testing services. The company's product portfolio comprises special satellite navigation products, conduction integration modules, test equipment, unmanned systems, radar product, navigational signal product, core devices and equipment and simulation systems Products among others. It also offers inertial navigation equipment, agricultural autopilot, instrumentation, fiber channel equipment, infrared thermal imaging instruments, Optical equipment and optoelectronic equipment. Hwa Create is headquartered in Beijing, Haidian, China.
-
Product Insights
NewNet Present Value Model: Sanofi’s INBRX-101
Empower your strategies with our Net Present Value Model: Sanofi's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed based...
-
Product Insights
NewNet Present Value Model: Inhibrx Inc’s INBRX-101
Empower your strategies with our Net Present Value Model: Inhibrx Inc's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed...
-
Thematic Analysis
NewTravel Apps – Thematic Intelligence
Travel Apps Thematic Intelligence Report Overview Apps are now expected as a part of a company's digital offerings. Travel apps have become popular due to the convenience they offer to travelers. Technology has allowed companies to create apps that offer a superior service to travelers, even excelling the online offering of a company. The travel apps thematic intelligence report provides in-depth insights into the travel apps theme and the emerging trends that will impact the use of these apps in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-102 in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TP-102 in Diabetic Foot Ulcers report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TP-102 in Diabetic Foot Ulcers Drug Details: TP-102 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GEN-3017 in T-Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GEN-3017 in T-Cell Lymphomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEN-3017 in T-Cell Lymphomas Drug Details: GEN-3017 (DuoBody-CD3xCD30) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GEN-3017 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GEN-3017 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEN-3017 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Cervical Cancer Drug Details: MT-302 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Gastric Cancer Drug Details: MT-302 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Esophageal Cancer Drug Details: MT-302 is under development for...